Celestial Biolabs surges on deciding to manufacture, market 21 life saving drugs in Allopathic range

14 Jan 2016 Evaluate

Celestial Biolabs is currently trading at Rs. 33.95, up by 1.95 points or 6.09% from its previous closing of Rs. 32.00 on the BSE.

The scrip opened at Rs. 31.50 and has touched a high and low of Rs. 35.00 and Rs. 29.40 respectively. So far 67,000 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 75.95 on 24-Apr-2015 and a 52 week low of Rs. 14.05 on 24-Jun-2015.

Last one week high and low of the scrip stood at Rs. 37.80 and Rs. 29.40 respectively. The current market cap of the company is Rs. 63.01 crore.

The promoters holding in the company stood at 38.81% while Non-Institutions held 61.19% respectively.

Celestial Biolabs has decided to introduce manufacturing and marketing of 21 life saving drugs in Allopathic range covering - Antibiotics, Analgesic & Anti-pyretics; Antiulcerants; Anti-Hypertensives; Anti-Diabetics; Anti-Fungal; Anti-Allergic; Anti-Emetic; Calcium Supplement; Steroid; Immune Suppressant and Topical Application for Wound Infection & Neurological disorders. This will enhance the company’s business sales volume & profitability in the times to come.

Celestial Biolabs is currently engaged in the business of manufacturing and sale of bio-pharmaceutical products. The company is already manufacturing and marketing Premium products In Herbal and Nutraceuticals range.


Celestial Biolabs Share Price

2.43 0.00 (0.00%)
11-Mar-2020 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.